Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Study of BAY43-9006 in Patients With Unresectable and/or Metastatic Renal Cell Cancer

ClinicalTrials.gov ID: NCT00073307

Public ClinicalTrials.gov record NCT00073307. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 26, 2026, 12:37 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase III Randomized Study of BAY43-9006 in Patients With Unresectable and/or Metastatic Renal Cell Cancer.

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to evaluate safety, efficacy (including quality of life), and pharmacokinetics of BAY43-9006 when added to Best Supportive Care in patients with unresectable and/or metastatic renal cell cancer, who have received one prior systemic regimen for advanced disease.

Study identification

NCT ID
NCT00073307
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Bayer
Industry
Enrollment
903 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Oct 31, 2003
Primary completion
Aug 31, 2006
Completion
Mar 31, 2010
Last update posted
Feb 5, 2014

2003 – 2010

United States locations

U.S. sites
31
U.S. states
22
U.S. cities
30
Facility City State ZIP Site status
Not listed Tucson Arizona 85712 —
Not listed Los Angeles California 90033 —
Not listed Los Angeles California 90057 —
Not listed Sacramento California 95817 —
Not listed Aurora Colorado 80045 —
Not listed Hamden Connecticut 06518 —
Not listed Atlanta Georgia 30309 —
Not listed Chicago Illinois 60637 —
Not listed Louisville Kentucky 40202 —
Not listed Lafayette Louisiana 70506 —
Not listed Frederick Maryland 21701 —
Not listed Boston Massachusetts 02215 —
Not listed Minneapolis Minnesota 55455 —
Not listed Columbia Missouri 65203-3244 —
Not listed St Louis Missouri 63110-1093 —
Not listed Brooklyn New York 11220 —
Not listed New York New York 10032 —
Not listed The Bronx New York 10466-2604 —
Not listed Canton Ohio 44718 —
Not listed Cleveland Ohio 44195 —
Not listed Dayton Ohio 45429 —
Not listed Portland Oregon 97239 —
Not listed Philadelphia Pennsylvania 19107-5096 —
Not listed Spartanburg South Carolina 29303 —
Not listed Dallas Texas 75246 —
Not listed Laredo Texas 78041 —
Not listed San Antonio Texas 78212 —
Not listed Salt Lake City Utah 84132 —
Not listed Richmond Virginia 23229 —
Not listed Seattle Washington 98101 —
Not listed Milwaukee Wisconsin 53226-3596 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 90 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00073307, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Feb 5, 2014 · Synced Sep 26, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00073307 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →